These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 28010132

  • 21. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials.
    Alsaeedi A, Sin DD, McAlister FA.
    Am J Med; 2002 Jul; 113(1):59-65. PubMed ID: 12106623
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia.
    Suissa S, Coulombe J, Ernst P.
    Chest; 2015 Nov; 148(5):1177-1183. PubMed ID: 26110239
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The place of inhaled corticosteroids in COPD].
    Chinet T, Dumoulin J, Honore I, Braun JM, Couderc LJ, Febvre M, Mangiapan G, Maurer C, Serrier P, Soyez F, Terrioux P, Jebrak G.
    Rev Mal Respir; 2016 Dec; 33(10):877-891. PubMed ID: 26831345
    [Abstract] [Full Text] [Related]

  • 29. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.
    Lin HW, Chung CL, Lin YS, Yu CM, Lee CN, Bien MY.
    PLoS One; 2015 Dec; 10(7):e0130102. PubMed ID: 26158649
    [Abstract] [Full Text] [Related]

  • 30. Inhaled and nasal corticosteroid use and the risk of fracture.
    Suissa S, Baltzan M, Kremer R, Ernst P.
    Am J Respir Crit Care Med; 2004 Jan 01; 169(1):83-8. PubMed ID: 14551165
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH, Perng DW, Chen CP, Chai WH, Yeh CS, Kor CT, Cheng SL, Chen JJ, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Jan 01; 11():3051-3058. PubMed ID: 27980402
    [Abstract] [Full Text] [Related]

  • 33. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts.
    Ernst P, Baltzan M, Deschênes J, Suissa S.
    Eur Respir J; 2006 Jun 01; 27(6):1168-74. PubMed ID: 16481387
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inhaled corticosteroids in COPD and the risk of serious pneumonia.
    Suissa S, Patenaude V, Lapi F, Ernst P.
    Thorax; 2013 Nov 01; 68(11):1029-36. PubMed ID: 24130228
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb 01; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 40. Use of inhaled corticosteroids and the risk of tuberculosis.
    Lee CH, Kim K, Hyun MK, Jang EJ, Lee NR, Yim JJ.
    Thorax; 2013 Dec 01; 68(12):1105-13. PubMed ID: 23749841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.